Active, Not Recruiting
Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects
NCT03012321
- Conditions
- Abnormal DNA Repair, Genital Diseases, Genital Diseases, Male, +11 more
- Locations
-
- University of California Los Angeles Los Angeles, California, United States
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Northwestern Medicine Chicago, Illinois, United States
- Rush University Cancer Center Chicago, Illinois, United States